LDL

Bempedoic acid, a cholesterol-lowering drug, has shown positive results in a large trial, reducing major adverse cardiovascular events by 13% in patients unable to tolerate statins. The study highlights the drug’s potential to offer a beneficial alternative for those unable to use first-line statin treatments, although its cholesterol-lowering effect is not as potent.Drug lowers LDL cholesterol and reduces the risk of serious cardiovascular outcomes in a large trial.The cholesterol-lowering drug bempedoic <span…

More than 200 million people around the world take statins with brand names such as Lipitor and Crestor daily to lower their bad cholesterol, known as LDL. Unfortunately, a majority fail to stick with their daily pills, putting them at risk of heart disease. First article More than 200 million people around the world take statins with brand…